¼öÀÇÇÐ ºÐÀÚÁø´Ü ¼¼°è ½ÃÀå ±Ô¸ð´Â 2030³â±îÁö 9¾ï 8,420¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î Àü¸Á
2023³â 5¾ï 9,650¸¸ ´Þ·¯·Î ÃßÁ¤µÇ´Â ¼öÀÇÇÐ ºÐÀÚÁø´Ü ¼¼°è ½ÃÀåÀº 2023³âºÎÅÍ 2030³â±îÁö ¿¬Æò±Õ 7.4% ¼ºÀåÇÏ¿© 2030³â¿¡´Â 9¾ï 8,420¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. º» º¸°í¼¿¡¼ ºÐ¼®ÇÑ ºÎ¹® Áß ÇϳªÀÎ ±â±â ¹× ¼ÒÇÁÆ®¿þ¾î´Â CAGR 7.2%¸¦ ±â·ÏÇÏ¿© ºÐ¼® ±â°£ Á¾·á ½ÃÁ¡¿¡ 3¾ï 4,280¸¸ ´Þ·¯¿¡ µµ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ŰƮ ¹× ½Ã¾à ºÎ¹®ÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£ µ¿¾È CAGR 8.3%·Î ÃßÁ¤µË´Ï´Ù.
¹Ì±¹ ½ÃÀåÀº 1¾ï 5,670¸¸ ´Þ·¯·Î ÃßÁ¤ ¹× ¿¹Ãø, Áß±¹Àº CAGR 11.0%·Î ¼ºÀå Àü¸Á
¹Ì±¹ÀÇ ¼öÀÇÇÐ ºÐÀÚÁø´Ü ½ÃÀåÀº 2023³â 1¾ï 5,670¸¸ ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ÀÇ °æÁ¦ ´ë±¹ÀÎ Áß±¹Àº 2030³â±îÁö 2¾ï 3,890¸¸ ´Þ·¯ ±Ô¸ð¿¡ µµ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, 2023-2030³â°£ 11.0%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)À» ³ªÅ¸³¾ Àü¸ÁÀÔ´Ï´Ù. ´Ù¸¥ ÁÖ¸ñÇÒ ¸¸ÇÑ Áö¿ª ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖÀ¸¸ç, ºÐ¼® ±â°£ µ¿¾È °¢°¢ 3.9%¿Í 6.6%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)À» ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. À¯·´¿¡¼´Â µ¶ÀÏÀÌ ¿¬Æò±Õ 4.6%ÀÇ ¼ºÀå·üÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
¼¼°è ¼öÀÇÇÐ ºÐÀÚÁø´Ü ½ÃÀå - ÁÖ¿ä µ¿Çâ ¹× ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ »ìÆìº¸±â
¼öÀÇÇÐ ºÐÀÚÁø´ÜÇÐÀÌ µ¿¹° °Ç°°ü¸®¿¡ Çõ¸íÀ» ÀÏÀ¸Å³ ¼ö ÀÖ´Â ÀÌÀ¯´Â ¹«¾ùÀΰ¡?
¼öÀÇÇÐ ºÐÀÚÁø´ÜÀº ºÐÀÚ ¼öÁØ¿¡¼ Á¤È®ÇÏ°í ½Å¼ÓÇÏ°Ô Áúº´À» °¨ÁöÇÒ ¼ö ÀÖ°Ô ÇÔÀ¸·Î½á µ¿¹° °Ç° °ü¸®ÀÇ Çõ½ÅÀûÀÎ µµ±¸·Î µîÀåÇß½À´Ï´Ù. ±×·¸´Ù¸é ¿Ö ÀÌ·± Áø´Ü¹ýÀÌ Çö´ë ¼öÀÇÇп¡ ÇʼöÀûÀÎ °ÍÀϱî? ¼öÀÇÇÐ ºÐÀÚÁø´ÜÇÐÀº µ¿¹°ÀÇ º´¿øÃ¼, Á¾¾ç, À¯ÀüÁúȯ¿¡¼ DNA, RNA¿Í °°Àº À¯Àü¹°ÁúÀ» ½Äº°Çϴ ÷´Ü °Ë»ç ±â¼úÀÔ´Ï´Ù. ÀÌ·¯ÇÑ °Ë»ç¿¡´Â ÁßÇÕÈ¿¼Ò¿¬¼â¹ÝÀÀ(PCR), ½Ç½Ã°£ PCR, Â÷¼¼´ë¿°±â¼¿ºÐ¼®(NGS), ¸¶ÀÌÅ©·Î¾î·¹ÀÌ µîÀÌ ÀÖÀ¸¸ç, º´¿øÃ¼, À¯ÀüÀÚ µ¹¿¬º¯ÀÌ, ¹ÙÀÌ¿À¸¶Ä¿¸¦ ³ôÀº ¹Î°¨µµ¿Í ƯÀ̼ºÀ¸·Î °ËÃâÇϰí Á¤·®ÈÇÒ ¼ö ÀÖ½À´Ï´Ù. Áúº´ÀÇ À¯ÀüÀû ±â¹ÝÀ» Ç¥ÀûÀ¸·Î »ï´Â ÀÌ·¯ÇÑ Áø´ÜÀº ¼öÀǻ簡 ÀÓ»ó Áõ»óÀÌ ³ªÅ¸³ª±â Àü¿¡ Áúº´À» Á¶±â¿¡ Áø´ÜÇÏ¿© Àû½Ã¿¡ °³ÀÔÇϰí Ä¡·áÇÒ ¼ö ÀÖ´Â Áß¿äÇÑ Ã¢±¸¸¦ Á¦°øÇÒ ¼ö ÀÖ½À´Ï´Ù.
¼öÀÇÇÐ ºÐÀÚÁø´Ü¿¡ ´ëÇÑ ¼ö¿ä´Â Àμö°øÅëÀü¿°º´ÀÇ È®»ê, µ¿¹°ÀÇ ¸¸¼º ¹× Àü¿°¼º ÁúȯÀÇ ¹ß»ý·ü Áõ°¡, ¿¹¹æÀû °Ç°°ü¸®¿¡ ´ëÇÑ °ü½É Áõ°¡¿¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Áø´ÜÀº ÆÄº¸¹ÙÀÌ·¯½º, °í¾çÀÌ ¹éÇ÷º´, ¼Ò È£Èí±â Áúȯ°ú °°Àº °¨¿°¼º ÁúȯÀÇ °ËÃâ°ú À¯Àü¼º ÁúȯÀÇ Àü¿°À» ¿¹¹æÇϱâ À§ÇÑ ¹ø½Ä ÇÁ·Î±×·¥ÀÇ À¯ÀüÀÚ °Ë»ç¿¡ ³Î¸® »ç¿ëµÇ°í ÀÖ½À´Ï´Ù. ºÐÀÚÁø´ÜÇÐÀº ¾Ï Ä¡·á¸¦ À§ÇÑ Ç¥Àû Ä¡·áÀÇ ÁöħÀÌ µÇ´Â ƯÁ¤ µ¹¿¬º¯ÀÌ ¹× ¹ÙÀÌ¿À¸¶Ä¿¸¦ ½Äº°ÇÏ´Â µ¥ »ç¿ëµÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ºÐÀÚÁø´ÜÀº ģô º´¿øÃ¼¸¦ ±¸º°Çϰí ÇÑ ¹øÀÇ °Ë»ç·Î ¿©·¯ º´¿øÃ¼¸¦ °ËÃâÇÒ ¼ö Àֱ⠶§¹®¿¡ ±âÁ¸ÀÇ °Ë»ç ¹æ¹ýÀ¸·Î´Â ÃæºÐÇÏÁö ¾ÊÀº º¹ÀâÇÑ »ç·Ê¿¡¼ ¼±È£µÇ´Â ¼±ÅÃÀÌ µÇ°í ÀÖ½À´Ï´Ù. ¹Ý·Áµ¿¹° º¸È£ÀÚ, °¡Ãà °ü¸®ÀÚ ¹× ¼öÀǻ簡 º¸´Ù Á¤È®ÇÏ°í ½Å·ÚÇÒ ¼ö ÀÖ´Â Áø´Ü ¼Ö·ç¼ÇÀ» ¿ä±¸ÇÔ¿¡ µû¶ó ¼öÀÇÇÐ ºÐÀÚÁø´ÜÀº µ¿¹° °Ç° °ü¸®¿¡¼ Á¡Á¡ ´õ Áß½ÉÀûÀÎ ¿ªÇÒÀ» ÇÏ°Ô µÉ °ÍÀÔ´Ï´Ù.
±â¼úÀÇ ¹ßÀüÀº ¼öÀÇÇÐ ºÐÀÚÁø´ÜÀÇ ¼º´ÉÀ» ¾î¶»°Ô Çâ»ó½Ã۰í Àִ°¡?
¼öÀÇÇÐ ºÐÀÚÁø´Ü ½ÃÀåÀº ÀÌ·¯ÇÑ Áø´Ü µµ±¸ÀÇ Á¤È®¼º, ¼Óµµ, Á¢±Ù¼ºÀ» Çâ»ó½ÃŰ´Â Áß¿äÇÑ ±â¼ú ¹ßÀüÀ» °æÇèÇß½À´Ï´Ù. ±×·¸´Ù¸é ÀÌ·¯ÇÑ ¹ßÀüÀÇ ¿øµ¿·ÂÀÌ µÈ ÁÖ¿ä ±â¼ú Çõ½ÅÀº ¹«¾ùÀϱî¿ä? °¡Àå ¿µÇâ·Â ÀÖ´Â ¹ßÀü Áß Çϳª´Â ½Ç½Ã°£ PCR(qPCR) ±â¼úÀÇ ¹ßÀüÀÔ´Ï´Ù. qPCRÀº ½Ç½Ã°£À¸·Î DNA ¶Ç´Â RNA ¼¿À» ÁõÆøÇϰí Á¤·®ÈÇÒ ¼ö ÀÖ´Â ´É·ÂÀ¸·Î ½Å¼ÓÇÏ°í ¹Î°¨ÇÑ °á°ú¸¦ Á¦°øÇÔÀ¸·Î½á µ¿¹° Áø´ÜÀÇ Ç¥ÁØÀÌ µÇ¾ú½À´Ï´Ù. ÃֽŠqPCR ½Ã½ºÅÛÀº ¸ÖƼÇ÷º½º ±â´ÉÀ» °®Ãß°í ÀÖ¾î ÇϳªÀÇ »ùÇÿ¡¼ ¿©·¯ º´¿øÃ¼ ¹× À¯ÀüÀÚ ¸¶Ä¿¸¦ µ¿½Ã¿¡ °ËÃâÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ±â¼ú Çõ½ÅÀ¸·Î ÀÎÇØ °Ë»ç ½Ã°£ÀÌ Å©°Ô ´ÜÃàµÇ°í, ¿©·¯ ¹ø °Ë»çÇÒ Çʿ䰡 ¾ø¾îÁ® ¼öÀǻ簡 º¸´Ù ½Å¼ÓÇϰí Á¤È®ÇÑ ÆÇ´ÜÀ» ³»¸± ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù. ¶ÇÇÑ ÀÚµ¿ ½Ã·á Áغñ ½Ã½ºÅÛÀÇ ÅëÇÕÀº ¿öÅ©Ç÷ο츦 °£¼ÒÈÇϰí ÀÎÀû ¿À·ùÀÇ °¡´É¼ºÀ» ÁÙ¿© °Ë»ç °á°úÀÇ Àϰü¼º°ú ½Å·Ú¼ºÀ» Çâ»ó½ÃÄ×½À´Ï´Ù.
¶Ç ´Ù¸¥ Áß¿äÇÑ Çõ½ÅÀº Â÷¼¼´ë ½ÃÄö½Ì(NGS) ±â¼úÀÇ µîÀåÀ¸·Î ¼öÀÇÇÐ À¯ÀüüÇÐ ºÐ¾ß¿¡ Çõ¸íÀ» ÀÏÀ¸Ä×À¸¸ç, NGS´Â Àüü À¯ÀüüÀ̳ª ƯÁ¤ ¿µ¿ªÀÇ ¿°±â¼¿À» °áÁ¤ÇÔÀ¸·Î½á Á¾ÇÕÀûÀÎ À¯ÀüÀÚ ºÐ¼®ÀÌ °¡´ÉÇØÁ® º¹ÀâÇÑ À¯ÀüÇüÁú, Áúº´ ¸ÞÄ¿´ÏÁò, ¹Ì»ý¹° ±ºÁý¿¡ ´ëÇÑ ÅëÂû·ÂÀ» ¾òÀ» ¼ö ÀÖ½À´Ï´Ù. ¸ÞÄ¿´ÏÁò, ¹Ì»ý¹° ±ºÁý¿¡ ´ëÇÑ ÅëÂû·ÂÀ» ¾òÀ» ¼ö ÀÖ½À´Ï´Ù. ÀÌ ±â¼úÀº º´¿øÃ¼ ¹ß°ß, Ç×±ÕÁ¦ ³»¼º ¸ð´ÏÅ͸µ, ¾Ï À¯ÀüÀÚÇü ºÐ¼® µî ¿¬±¸ ¹× ÀÓ»ó¿¡¼ Á¡Á¡ ´õ ¸¹ÀÌ »ç¿ëµÇ°í ÀÖ½À´Ï´Ù. ÈÞ´ë¿ë ¹× ÇöÀå Áø·áÇü ºÐÀÚÁø´Ü ÀåºñÀÇ °³¹ß·Î ÀÌ·¯ÇÑ ±â¼úÀÇ È°¿ë ¹üÀ§°¡ ´õ¿í È®´ëµÇ¾î ¼öÀǻ簡 Áø·á¼Ò, ³óÀå, ÇöÀå µî ÇöÀå¿¡¼ °Ë»ç¸¦ ½Ç½ÃÇÒ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù. ÀÌ·¯ÇÑ Àåºñ´Â »ç¿ëÀÚ Ä£ÈÀûÀ¸·Î ¼³°èµÇ¾î ÃÖ¼ÒÇÑÀÇ ±³À°À̳ª ÀÎÇÁ¶ó°¡ ÇÊ¿äÇϱ⠶§¹®¿¡ ¿ø°ÝÁö³ª ÀÚ¿øÀÌ Á¦ÇÑµÈ È¯°æ¿¡¼µµ °í±Þ ºÐÀÚÁø´Ü¿¡ Á¢±ÙÇÒ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ, »ý¹°Á¤º¸ÇÐ ¹× µ¥ÀÌÅÍ ºÐ¼®ÀÇ ¹ßÀüÀº ºÐÀÚÁø´Ü °á°úÀÇ ÇØ¼®À» °ÈÇÏ¿© º¸´Ù Á¤È®ÇÏ°í ½Ç¿ëÀûÀÎ ÅëÂû·ÂÀ» Á¦°øÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ±â¼ú Çõ½ÅÀº ¼öÀÇÇÐ ºÐÀÚÁø´ÜÀÇ ¼º´É°ú ½Ç¿ë¼ºÀ» Çâ»ó½ÃÄÑ Çö´ë ¼öÀÇÇп¡ ÇʼöÀûÀÎ µµ±¸·Î ÀÚ¸®¸Å±èÇϰí ÀÖ½À´Ï´Ù.
µ¿¹° °Ç°°ü¸®¿¡¼ ¼öÀÇÇÐ ºÐÀÚÁø´ÜÀÇ º¸±ÞÀ» ÃËÁøÇÏ´Â ½ÃÀå µ¿ÇâÀº ¹«¾ùÀΰ¡?
¼öÀÇ»ç, ¿¬±¸ÀÚ, º¸È£ÀÚÀÇ ÁøÈÇÏ´Â ¿ä±¸¿Í ±â´ë¸¦ ¹Ý¿µÇÏ¿© ¸î °¡Áö »õ·Î¿î ½ÃÀå Æ®·»µå°¡ µ¿¹° °Ç° °ü¸® ºÐ¾ß¿¡¼ ¼öÀÇÇÐ ºÐÀÚÁø´ÜÀÇ Ã¤ÅÃÀ» Çü¼ºÇϰí ÀÖ½À´Ï´Ù. °¡Àå µÎµå·¯Áø Æ®·»µå Áß Çϳª´Â ¿¹¹æ ÀÇ·á¿Í Áúº´ Á¶±â ¹ß°ß¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁö°í ÀÖ´Ù´Â Á¡ÀÔ´Ï´Ù. ¹Ý·Áµ¿¹° º¸È£ÀÚ¿Í °¡Ãà °ü¸®ÀÚµéÀÌ Á¶±â Áø´ÜÀÇ ÀÌÁ¡À» ´õ ¸¹ÀÌ ÀνÄÇÔ¿¡ µû¶ó, Áúº´ÀÌ Áõ»óÀÌ ³ªÅ¸³ª°Å³ª ´Ù¸¥ µ¿¹°¿¡°Ô Àü¿°µÇ±â Àü¿¡ ¹«Áõ»ó ´Ü°è¿¡¼ Áúº´À» °¨ÁöÇÒ ¼ö ÀÖ´Â Áø´Ü µµ±¸¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ³ôÀº ¹Î°¨µµ¿Í ƯÀ̼ºÀ» °¡Áø ¼öÀÇÇÐ ºÐÀÚÁø´ÜÀº ÀÌ·¯ÇÑ ¸ñÀû¿¡ ÀûÇÕÇϸç, °¨¿°¼º º´¿øÃ¼, À¯ÀüÀû Áúȯ, ¾Ï¼¼Æ÷¸¦ Á¶±â¿¡ ½Äº°ÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Ãß¼¼´Â Á¤±âÀûÀÎ °Ç°°ËÁø°ú À£´Ï½º ÇÁ·Î±×·¥ÀÌ º¸Æíȵǰí ÀÖ´Â ¹Ý·Áµ¿¹° ºÐ¾ß¿¡¼ ƯÈ÷ µÎµå·¯Áö°Ô ³ªÅ¸³ª°í ÀÖ½À´Ï´Ù. À¯ÀüÀû ¼ÒÀΰú °¨¿°À» Á¶±â¿¡ ¹ß°ßÇÒ ¼ö ÀÖ´Â ´É·ÂÀº ¼öÀǻ簡 ¸ÂÃãÇü ¿¹¹æ Á¶Ä¡¸¦ ½ÃÇàÇÏ°í ¸ÂÃã Ä¡·á °èȹÀ» ¼ö¸³ÇÒ ¼ö ÀÖ°Ô ÇÔÀ¸·Î½á °Ç° »óŸ¦ °³¼±Çϰí Àå±âÀûÀ¸·Î Ä¡·á ºñ¿ëÀ» Àý°¨ÇÒ ¼ö ÀÖ°Ô ÇÕ´Ï´Ù.
¼öÀÇÇÐ ºÐÀÚÁø´ÜÀÇ µµÀÔÀ» ÃËÁøÇÏ´Â ¶Ç ´Ù¸¥ Áß¿äÇÑ Ãß¼¼´Â Àμö°øÅëÀü¿°º´ Áõ°¡¿Í È¿°úÀûÀÎ Áúº´ °¨½ÃÀÇ Çʿ伺ÀÔ´Ï´Ù. µ¿¹°°ú »ç¶÷ »çÀÌ¿¡ Àü¿°µÇ´Â Àμö°øÅëÀü¿°º´Àº °øÁߺ¸°Ç»ó ½É°¢ÇÑ À§ÇèÀ̸ç, ¹ß»ýÀ» ¾ïÁ¦Çϰí Á¾°£ ÀüÆÄ¸¦ ¸·±â À§Çؼ´Â Á¶±â¿¡ Á¤È®ÇÑ Áø´ÜÀÌ ÇʼöÀûÀ̸ç, Äڷγª19ÀÇ ´ëÀ¯ÇàÀº °·ÂÇÑ Áúº´ °¨½Ã ½Ã½ºÅÛÀÇ Á߿伺À» °Á¶Çϰí ÀÖÀ¸¸ç, ¹Ý·Áµ¿¹°°ú °¡ÃàÀÇ Áø´Ü ÀÎÇÁ¶ó¿¡ ´ëÇÑ ÅõÀÚ È®´ë·Î À̾îÁ³½À´Ï´Ù. ¼öÀÇÇÐ ºÐÀÚÁø´ÜÀº ¼öÀÇÇÐ ºÐÀÚÁø´ÜÀº Àμö°øÅëÀü¿°º´ º´¿øÃ¼¸¦ ½Å¼ÓÇϰí Á¤È®ÇÏ°Ô Å½ÁöÇÒ ¼ö ÀÖ´Â µµ±¸¸¦ Á¦°øÇÔÀ¸·Î½á Áúº´ È®»êÀ» ÃßÀûÇϰí ÅëÁ¦Çϱâ À§ÇÑ ³ë·ÂÀ» Áö¿øÇÏ´Â µ¥ Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Ãß¼¼´Â ºÏ¹Ì¿Í À¯·´ µî °¡ÃàÀÌ ¸¹Àº Áö¿ª¿¡¼ ƯÈ÷ µÎµå·¯Áö°Ô ³ªÅ¸³ª°í ÀÖÀ¸¸ç, Á¶·ù ÀÎÇ÷翣ÀÚ, ¼Ò °áÇÙ, ¾ÆÇÁ¸®Ä«µÅÁö¿º´ µîÀÇ Áúº´À» °¨½ÃÇÏ´Â µ¥ ºÐÀÚÁø´ÜÀÌ È°¿ëµÇ°í ÀÖ½À´Ï´Ù. Á¾ÇÕÀûÀÎ Áúº´ °¨½Ã ¹× ¹ÙÀÌ¿À º¸¾È Á¶Ä¡¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÔ¿¡ µû¶ó ¹Î°ü ºÎ¹® ¸ðµÎ¿¡¼ ºÐÀÚÁø´ÜÀÇ Ã¤ÅÃÀ» Áö¼ÓÀûÀ¸·Î ÃËÁøÇÏ°í µ¿¹° °Ç° °ü¸®ÀÇ Áß¿äÇÑ ¼ö´ÜÀ¸·Î¼ÀÇ ¿ªÇÒÀ» °ÈÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
¼öÀÇÇÐ ºÐÀÚÁø´Ü ¼¼°è ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎÀº?
¼¼°è ¼öÀÇÇÐ ºÐÀÚÁø´Ü ½ÃÀåÀÇ ¼ºÀåÀº Áø´Ü ±â¼úÀÇ ¹ßÀü, µ¿¹° °Ç° °ü¸®¿¡ ´ëÇÑ ÅõÀÚ Áõ°¡, Àμö°øÅëÀü¿°º´¿¡ ´ëÇÑ ÀÎ½Ä Áõ°¡ µî ¿©·¯ °¡Áö ¿äÀο¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖ½À´Ï´Ù. ÁÖ¿ä ¼ºÀå ¿äÀÎ Áß Çϳª´Â ¹Ý·Áµ¿¹° Àα¸ Áõ°¡¿Í ¹Ý·Áµ¿¹°ÀÇ Àΰ£ÈÀ̸ç, ¹Ý·Áµ¿¹° º¸È£ÀÚµéÀº µ¿¹°À» °¡Á·ÀÇ ÀÏ¿øÀ¸·Î ¿©±â°í °í±Þ ÀÇ·á ¼ºñ½º¿¡ ±â²¨ÀÌ ÅõÀÚÇϰí ÀÖ½À´Ï´Ù. ÀÌ¿¡ µû¶ó ½Å¼ÓÇϰí Á¤È®ÇÑ °á°ú¸¦ Á¦°øÇÏ¿© Á¶±â Áø´Ü°ú È¿°úÀûÀÎ Ä¡·á¸¦ °¡´ÉÇÏ°Ô ÇÏ´Â Áø´Ü °Ë»ç¿¡ ´ëÇÑ ¼ö¿ä°¡ ±ÞÁõÇϰí ÀÖ½À´Ï´Ù. »ç¿ëÀÚ Ä£ÈÀûÀ̰í ÀÚµ¿ÈµÈ ºÐÀÚÁø´Ü Ç÷§ÆûÀÇ °³¹ß·Î µ¿¹°º´¿ø ¹× Ŭ¸®´ÐÀº ÀÌ·¯ÇÑ °Ë»ç¸¦ ÀÏ»óÀûÀÎ Áø´Ü ¾÷¹«¿¡ ½±°Ô ÅëÇÕÇÒ ¼ö ÀÖ°Ô µÇ¾î ½ÃÀå ¼ºÀå¿¡ ´õ¿í ¹ÚÂ÷¸¦ °¡ÇÒ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù. ³ó°¡¿Í »ý»êÀÚµéÀÌ °¡ÃàÀÇ °Ç°, »ý»ê¼º ¹× Áúº´ °ü¸®¸¦ °³¼±Çϱâ À§ÇØ ³ë·ÂÇÏ¸é¼ °¡Ãà °ü¸®¿¡¼ ºÐÀÚÁø´ÜÀÇ »ç¿ëÀÌ Áõ°¡Çϰí ÀÖ´Â °Íµµ ÁÖ¿ä ÃËÁø¿äÀÎÀ¸·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù.
°¨¿°º´ ¹ß»ý·ü Áõ°¡¿Í È¿°úÀûÀÎ Áúº´ °ü¸® ¹× ÅëÁ¦ÀÇ Çʿ伺ÀÌ Áõ°¡Çϰí ÀÖ´Â °Íµµ Áß¿äÇÑ ÃËÁø¿äÀÎÀÔ´Ï´Ù. Á¶·ùµ¶°¨, ¾ÆÇÁ¸®Ä«µÅÁö¿º´, °³ ÆÄº¸¹ÙÀÌ·¯½º¿Í °°Àº Áúº´ÀÇ ¹ß»ýÀº Áúº´ÀÇ È®»êÀ» ¹æÁöÇÏ°í °æÁ¦Àû ¼Õ½ÇÀ» ÃÖ¼ÒÈÇϱâ À§ÇØ ½Å¼ÓÇϰí Á¤È®ÇÑ Áø´ÜÀÇ Á߿伺À» °Á¶Çϰí ÀÖ½À´Ï´Ù. ¼öÀÇÇÐ ºÐÀÚÁø´ÜÇÐÀº º´¿øÃ¼ °ËÃâ ¹× °¨º°À» À§ÇÑ ½Å·ÚÇÒ ¼ö ÀÖ´Â ¼Ö·ç¼ÇÀ» Á¦°øÇÏ¿© ¼öÀǻ簡 Àû½Ã¿¡ ÀûÀýÇÑ °³ÀÔÀ» ÇÒ ¼ö ÀÖµµ·Ï µ½½À´Ï´Ù. Ç×±ÕÁ¦ ³»¼º(AMR)¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁø °Íµµ ½ÃÀå ¼ºÀå¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ºÐÀÚÁø´ÜÀº ³»¼º À¯ÀüÀÚ¸¦ ½Äº°Çϰí Ç×»ýÁ¦ÀÇ ÀûÀýÇÑ »ç¿ëÀ» À¯µµÇÏ¿© ³»¼º ¹ßÇöÀÇ À§ÇèÀ» ÁÙÀÏ ¼ö Àֱ⠶§¹®ÀÔ´Ï´Ù. ¶ÇÇÑ, ƯÈ÷ ¾Æ½Ã¾ÆÅÂÆò¾ç°ú ¶óƾ¾Æ¸Þ¸®Ä« µî ½ÅÈï ½ÃÀå¿¡¼ µ¿¹° Áø´Ü ½ÇÇè½Ç ¹× ¿¬±¸±â°üÀÇ È®ÀåÀº ½ÃÀå ¼ºÀåÀÇ »õ·Î¿î ±âȸ¸¦ âÃâÇϰí ÀÖ½À´Ï´Ù. À̵é Áö¿ª¿¡¼´Â ¼öÀÇÇÐ ÀÎÇÁ¶ó Çö´ëÈ¿Í Ã·´Ü Áø´Ü ±â¼ú¿¡ ´ëÇÑ Á¢±Ù¼º °³¼±¿¡ ÅõÀÚÇϰí ÀÖ¾î, ±â¼ú Çõ½Å, ÁøÈÇÏ´Â ÀÇ·á °üÇà, µ¿¹° ¹× °øÁߺ¸°Ç¿¡ ´ëÇÑ ÀνÄÀÌ ¿ªµ¿ÀûÀ¸·Î »óÈ£ÀÛ¿ëÇÏ¸é¼ ¼¼°è ¼öÀÇÇÐ ºÐÀÚÁø´Ü ½ÃÀåÀº Áö¼ÓÀûÀ¸·Î È®´ëµÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
Á¶»ç ´ë»ó ±â¾÷ ¿¹½Ã(ÃÑ 42°Ç)
- BIOMEDICA Medizinprodukte GmbH & Co.
- Bioneer Corporation
- HealthGene Corporation
- Idexx Laboratories, Inc.
- Novacyt Group
- Qiagen NV
- Thermo Fisher Scientific, Inc.
- Vca, Inc.
¸ñÂ÷
Á¦1Àå Á¶»ç ¹æ¹ý
Á¦2Àå ÁÖ¿ä ¿ä¾à
- ½ÃÀå °³¿ä
- ÁÖ¿ä ±â¾÷
- ½ÃÀå µ¿Çâ°ú ÃËÁø¿äÀÎ
- ¼¼°è ½ÃÀå Àü¸Á
Á¦3Àå ½ÃÀå ºÐ¼®
- ¹Ì±¹
- ij³ª´Ù
- ÀϺ»
- Áß±¹
- À¯·´
- ÇÁ¶û½º
- µ¶ÀÏ
- ÀÌÅ»¸®¾Æ
- ¿µ±¹
- ½ºÆäÀÎ
- ·¯½Ã¾Æ
- ±âŸ À¯·´
- ¾Æ½Ã¾ÆÅÂÆò¾ç
- È£ÁÖ
- Àεµ
- Çѱ¹
- ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
- ¶óƾ¾Æ¸Þ¸®Ä«
- ¾Æ¸£ÇîÆ¼³ª
- ºê¶óÁú
- ¸ß½ÃÄÚ
- ±âŸ ¶óƾ¾Æ¸Þ¸®Ä«
- 秵- À̶õ
- À̽º¶ó¿¤
- »ç¿ìµð¾Æ¶óºñ¾Æ
- ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
- ±âŸ Áßµ¿
- ¾ÆÇÁ¸®Ä«
Á¦4Àå °æÀï
LSH
Global Veterinary Molecular Diagnostics Market to Reach US$984.2 Million by 2030
The global market for Veterinary Molecular Diagnostics estimated at US$596.5 Million in the year 2023, is expected to reach US$984.2 Million by 2030, growing at a CAGR of 7.4% over the analysis period 2023-2030. Instruments & Software, one of the segments analyzed in the report, is expected to record a 7.2% CAGR and reach US$342.8 Million by the end of the analysis period. Growth in the Kits & Reagents segment is estimated at 8.3% CAGR over the analysis period.
The U.S. Market is Estimated at US$156.7 Million While China is Forecast to Grow at 11.0% CAGR
The Veterinary Molecular Diagnostics market in the U.S. is estimated at US$156.7 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$238.9 Million by the year 2030 trailing a CAGR of 11.0% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.9% and 6.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.6% CAGR.
Global Veterinary Molecular Diagnostics Market - Key Trends & Growth Drivers Explored
Why Are Veterinary Molecular Diagnostics Revolutionizing Animal Health Management?
Veterinary molecular diagnostics have emerged as a transformative tool in animal healthcare, enabling precise and rapid detection of diseases at the molecular level. But what makes these diagnostic methods so essential in modern veterinary practices? Veterinary molecular diagnostics are advanced testing techniques that identify genetic material, such as DNA and RNA, from pathogens, tumors, or genetic disorders in animals. These tests include polymerase chain reaction (PCR), real-time PCR, next-generation sequencing (NGS), and microarrays, among others, which can detect and quantify pathogens, genetic mutations, or biomarkers with high sensitivity and specificity. By targeting the genetic basis of diseases, these diagnostics allow veterinarians to diagnose conditions early, often before clinical symptoms appear, providing a crucial window for timely intervention and treatment.
The demand for veterinary molecular diagnostics is driven by the growing prevalence of zoonotic diseases, the rising incidence of chronic and infectious conditions in animals, and the increasing focus on preventive healthcare. These diagnostics are widely used in the detection of infectious diseases such as parvovirus, feline leukemia, and bovine respiratory disease, as well as for genetic screening in breeding programs to prevent the transmission of hereditary disorders. Molecular diagnostics have also become indispensable in the field of oncology, where they are used to identify specific mutations and biomarkers that can guide targeted therapies for cancer treatment. Furthermore, the ability to differentiate between closely related pathogens and detect multiple pathogens in a single test has made molecular diagnostics a preferred choice in complex cases where traditional testing methods may fall short. As pet owners, livestock managers, and veterinarians seek more accurate and reliable diagnostic solutions, veterinary molecular diagnostics are poised to play an increasingly central role in animal health management.
How Are Technological Advancements Elevating the Performance of Veterinary Molecular Diagnostics?
The veterinary molecular diagnostics market has experienced significant technological advancements that have enhanced the precision, speed, and accessibility of these diagnostic tools. But what are the key innovations driving these developments? One of the most impactful advancements is the evolution of real-time PCR (qPCR) technology. qPCR has become a gold standard in veterinary diagnostics due to its ability to amplify and quantify DNA or RNA sequences in real-time, providing rapid and highly sensitive results. Modern qPCR systems are equipped with multiplexing capabilities, allowing the simultaneous detection of multiple pathogens or genetic markers in a single sample. This innovation has significantly reduced turnaround times and the need for multiple tests, enabling veterinarians to make quicker and more informed decisions. Additionally, the integration of automated sample preparation systems has streamlined the workflow, reducing the potential for human error and increasing the consistency and reliability of test results.
Another critical innovation is the advent of next-generation sequencing (NGS) technology, which has revolutionized the field of veterinary genomics. NGS allows for comprehensive genetic analysis by sequencing entire genomes or targeted regions of interest, providing insights into complex genetic traits, disease mechanisms, and microbial communities. This technology is being increasingly used in research and clinical settings for applications such as pathogen discovery, antimicrobial resistance monitoring, and cancer genotyping. The development of portable and point-of-care molecular diagnostic devices has further expanded the reach of these technologies, enabling veterinarians to conduct testing on-site, whether in clinics, farms, or field settings. These devices are designed to be user-friendly, requiring minimal training and infrastructure, making advanced molecular diagnostics accessible even in remote or resource-limited environments. Furthermore, advancements in bioinformatics and data analytics have enhanced the interpretation of molecular diagnostic results, allowing for more accurate and actionable insights. These technological innovations have collectively elevated the performance and utility of veterinary molecular diagnostics, making them indispensable tools for modern veterinary medicine.
What Market Trends Are Driving the Adoption of Veterinary Molecular Diagnostics Across Animal Healthcare?
Several emerging market trends are shaping the adoption of veterinary molecular diagnostics across the animal healthcare sector, reflecting the evolving needs and expectations of veterinarians, researchers, and pet owners. One of the most prominent trends is the increasing focus on preventive care and early disease detection. As pet owners and livestock managers become more aware of the benefits of early diagnosis, there is a growing demand for diagnostic tools that can detect diseases at the subclinical stage, before they become symptomatic or spread to other animals. Veterinary molecular diagnostics, with their high sensitivity and specificity, are well-suited for this purpose, allowing for the early identification of infectious agents, genetic disorders, and cancerous cells. This trend is particularly strong in the companion animal sector, where regular health screenings and wellness programs are becoming more common. The ability to detect genetic predispositions and infectious diseases early enables veterinarians to implement targeted preventive measures and develop personalized treatment plans, improving health outcomes and reducing the long-term costs of care.
Another key trend driving the adoption of veterinary molecular diagnostics is the rising prevalence of zoonotic diseases and the need for effective disease surveillance. Zoonotic diseases, which are transmitted between animals and humans, pose a significant public health risk, making early and accurate diagnosis essential for controlling outbreaks and preventing cross-species transmission. The COVID-19 pandemic has underscored the importance of robust disease surveillance systems, leading to increased investment in diagnostic infrastructure for both companion animals and livestock. Veterinary molecular diagnostics are playing a critical role in this effort by providing tools that can detect zoonotic pathogens rapidly and accurately, supporting efforts to track and control disease spread. This trend is particularly evident in regions with large livestock populations, such as North America and Europe, where molecular diagnostics are used to monitor diseases like avian influenza, bovine tuberculosis, and African swine fever. The growing demand for comprehensive disease surveillance and biosecurity measures is expected to continue driving the adoption of molecular diagnostics in both the public and private sectors, reinforcing their role as key instruments in animal health management.
What Factors Are Driving the Growth of the Global Veterinary Molecular Diagnostics Market?
The growth in the global veterinary molecular diagnostics market is driven by several factors, including advancements in diagnostic technology, increasing investment in animal healthcare, and rising awareness of zoonotic diseases. One of the primary growth drivers is the expanding pet population and the humanization of pets, where owners treat their animals as family members and are willing to invest in advanced healthcare services. This has led to a surge in demand for diagnostic tests that provide quick and accurate results, enabling early diagnosis and effective treatment. The development of user-friendly and automated molecular diagnostic platforms has made it easier for veterinary clinics and hospitals to incorporate these tests into their routine diagnostic offerings, further boosting market growth. The increasing use of molecular diagnostics in livestock management is another key growth driver, as farmers and producers seek to improve herd health, productivity, and disease control.
Another significant growth driver is the rising incidence of infectious diseases and the growing need for effective disease management and control. Outbreaks of diseases like avian influenza, African swine fever, and canine parvovirus have highlighted the importance of rapid and accurate diagnostics for preventing disease spread and minimizing economic losses. Veterinary molecular diagnostics provide a reliable solution for detecting and differentiating pathogens, enabling veterinarians to implement timely and targeted interventions. The growing focus on antimicrobial resistance (AMR) is also contributing to market growth, as molecular diagnostics can identify resistance genes and guide the appropriate use of antibiotics, reducing the risk of resistance development. Furthermore, the expansion of veterinary diagnostic laboratories and research institutions, particularly in emerging markets such as Asia-Pacific and Latin America, is creating new opportunities for market growth. As these regions invest in modernizing their veterinary infrastructure and improving access to advanced diagnostic technologies, the global veterinary molecular diagnostics market is poised for sustained expansion, driven by a dynamic interplay of technological innovation, evolving healthcare practices, and increasing awareness of animal and public health.
Select Competitors (Total 42 Featured) -
- BIOMEDICA Medizinprodukte GmbH & Co., KG
- Bioneer Corporation
- HealthGene Corporation
- Idexx Laboratories, Inc.
- Novacyt Group
- Qiagen NV
- Thermo Fisher Scientific, Inc.
- Vca, Inc.
TABLE OF CONTENTS
I. METHODOLOGY
II. EXECUTIVE SUMMARY
- 1. MARKET OVERVIEW
- Influencer Market Insights
- World Market Trajectories
- Veterinary Molecular Diagnostics - Global Key Competitors Percentage Market Share in 2024 (E)
- Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
- 2. FOCUS ON SELECT PLAYERS
- 3. MARKET TRENDS & DRIVERS
- Rising Incidence of Infectious Diseases in Companion and Livestock Animals Drives Demand for Veterinary Molecular Diagnostics
- Increased Adoption of Molecular Diagnostic Techniques in Veterinary Clinics and Laboratories Expands Addressable Market
- Rising Use of Molecular Diagnostics in Zoonotic Disease Surveillance Sets the Stage for Market Growth
- Surge in Demand for Molecular Diagnostic Tests in Food Safety and Animal Health Monitoring Expands Market Opportunities
- Growing Adoption of Molecular Diagnostics in Veterinary Oncology and Genetic Disease Testing Strengthens Business Case
- Technological Advancements in Multiplex and High-Throughput Molecular Diagnostic Platforms Propel Market Expansion
- Growing Use of Molecular Diagnostics in Animal Reproductive Health and Fertility Management Strengthens Market Growth
- Surge in Use of Molecular Diagnostic Techniques in Wildlife and Conservation Medicine Expands Market Opportunities
- 4. GLOBAL MARKET PERSPECTIVE
- TABLE 1: World Veterinary Molecular Diagnostics Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
- TABLE 2: World Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
- TABLE 3: World Historic Review for Veterinary Molecular Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 4: World 16-Year Perspective for Veterinary Molecular Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
- TABLE 5: World Recent Past, Current & Future Analysis for Instruments & Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
- TABLE 6: World Historic Review for Instruments & Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 7: World 16-Year Perspective for Instruments & Software by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
- TABLE 8: World Recent Past, Current & Future Analysis for Kits & Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
- TABLE 9: World Historic Review for Kits & Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 10: World 16-Year Perspective for Kits & Reagents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
- TABLE 11: World Recent Past, Current & Future Analysis for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
- TABLE 12: World Historic Review for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 13: World 16-Year Perspective for Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
- TABLE 14: World Recent Past, Current & Future Analysis for Polymerase Chain Reaction (PCR) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
- TABLE 15: World Historic Review for Polymerase Chain Reaction (PCR) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 16: World 16-Year Perspective for Polymerase Chain Reaction (PCR) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
- TABLE 17: World Recent Past, Current & Future Analysis for Microarrays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
- TABLE 18: World Historic Review for Microarrays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 19: World 16-Year Perspective for Microarrays by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
- TABLE 20: World Recent Past, Current & Future Analysis for DNA Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
- TABLE 21: World Historic Review for DNA Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 22: World 16-Year Perspective for DNA Sequencing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
- TABLE 23: World Recent Past, Current & Future Analysis for Hospitals/Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
- TABLE 24: World Historic Review for Hospitals/Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 25: World 16-Year Perspective for Hospitals/Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
- TABLE 26: World Recent Past, Current & Future Analysis for Reference Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
- TABLE 27: World Historic Review for Reference Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 28: World 16-Year Perspective for Reference Laboratories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
III. MARKET ANALYSIS
- UNITED STATES
- Veterinary Molecular Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
- TABLE 29: USA Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 30: USA Historic Review for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 31: USA 16-Year Perspective for Veterinary Molecular Diagnostics by Product Segment - Percentage Breakdown of Value Sales for Instruments & Software, Kits & Reagents and Services for the Years 2014, 2024 & 2030
- TABLE 32: USA Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 33: USA Historic Review for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 34: USA 16-Year Perspective for Veterinary Molecular Diagnostics by Technology Type - Percentage Breakdown of Value Sales for Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing for the Years 2014, 2024 & 2030
- TABLE 35: USA Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 36: USA Historic Review for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 37: USA 16-Year Perspective for Veterinary Molecular Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals/Clinics and Reference Laboratories for the Years 2014, 2024 & 2030
- CANADA
- TABLE 38: Canada Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 39: Canada Historic Review for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 40: Canada 16-Year Perspective for Veterinary Molecular Diagnostics by Product Segment - Percentage Breakdown of Value Sales for Instruments & Software, Kits & Reagents and Services for the Years 2014, 2024 & 2030
- TABLE 41: Canada Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 42: Canada Historic Review for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 43: Canada 16-Year Perspective for Veterinary Molecular Diagnostics by Technology Type - Percentage Breakdown of Value Sales for Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing for the Years 2014, 2024 & 2030
- TABLE 44: Canada Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 45: Canada Historic Review for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 46: Canada 16-Year Perspective for Veterinary Molecular Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals/Clinics and Reference Laboratories for the Years 2014, 2024 & 2030
- JAPAN
- Veterinary Molecular Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
- TABLE 47: Japan Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 48: Japan Historic Review for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 49: Japan 16-Year Perspective for Veterinary Molecular Diagnostics by Product Segment - Percentage Breakdown of Value Sales for Instruments & Software, Kits & Reagents and Services for the Years 2014, 2024 & 2030
- TABLE 50: Japan Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 51: Japan Historic Review for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 52: Japan 16-Year Perspective for Veterinary Molecular Diagnostics by Technology Type - Percentage Breakdown of Value Sales for Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing for the Years 2014, 2024 & 2030
- TABLE 53: Japan Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 54: Japan Historic Review for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 55: Japan 16-Year Perspective for Veterinary Molecular Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals/Clinics and Reference Laboratories for the Years 2014, 2024 & 2030
- CHINA
- Veterinary Molecular Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
- TABLE 56: China Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 57: China Historic Review for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 58: China 16-Year Perspective for Veterinary Molecular Diagnostics by Product Segment - Percentage Breakdown of Value Sales for Instruments & Software, Kits & Reagents and Services for the Years 2014, 2024 & 2030
- TABLE 59: China Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 60: China Historic Review for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 61: China 16-Year Perspective for Veterinary Molecular Diagnostics by Technology Type - Percentage Breakdown of Value Sales for Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing for the Years 2014, 2024 & 2030
- TABLE 62: China Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 63: China Historic Review for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 64: China 16-Year Perspective for Veterinary Molecular Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals/Clinics and Reference Laboratories for the Years 2014, 2024 & 2030
- EUROPE
- Veterinary Molecular Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
- TABLE 65: Europe Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
- TABLE 66: Europe Historic Review for Veterinary Molecular Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 67: Europe 16-Year Perspective for Veterinary Molecular Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
- TABLE 68: Europe Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 69: Europe Historic Review for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 70: Europe 16-Year Perspective for Veterinary Molecular Diagnostics by Product Segment - Percentage Breakdown of Value Sales for Instruments & Software, Kits & Reagents and Services for the Years 2014, 2024 & 2030
- TABLE 71: Europe Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 72: Europe Historic Review for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 73: Europe 16-Year Perspective for Veterinary Molecular Diagnostics by Technology Type - Percentage Breakdown of Value Sales for Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing for the Years 2014, 2024 & 2030
- TABLE 74: Europe Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 75: Europe Historic Review for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 76: Europe 16-Year Perspective for Veterinary Molecular Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals/Clinics and Reference Laboratories for the Years 2014, 2024 & 2030
- FRANCE
- Veterinary Molecular Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
- TABLE 77: France Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 78: France Historic Review for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 79: France 16-Year Perspective for Veterinary Molecular Diagnostics by Product Segment - Percentage Breakdown of Value Sales for Instruments & Software, Kits & Reagents and Services for the Years 2014, 2024 & 2030
- TABLE 80: France Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 81: France Historic Review for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 82: France 16-Year Perspective for Veterinary Molecular Diagnostics by Technology Type - Percentage Breakdown of Value Sales for Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing for the Years 2014, 2024 & 2030
- TABLE 83: France Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 84: France Historic Review for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 85: France 16-Year Perspective for Veterinary Molecular Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals/Clinics and Reference Laboratories for the Years 2014, 2024 & 2030
- GERMANY
- Veterinary Molecular Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
- TABLE 86: Germany Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 87: Germany Historic Review for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 88: Germany 16-Year Perspective for Veterinary Molecular Diagnostics by Product Segment - Percentage Breakdown of Value Sales for Instruments & Software, Kits & Reagents and Services for the Years 2014, 2024 & 2030
- TABLE 89: Germany Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 90: Germany Historic Review for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 91: Germany 16-Year Perspective for Veterinary Molecular Diagnostics by Technology Type - Percentage Breakdown of Value Sales for Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing for the Years 2014, 2024 & 2030
- TABLE 92: Germany Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 93: Germany Historic Review for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 94: Germany 16-Year Perspective for Veterinary Molecular Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals/Clinics and Reference Laboratories for the Years 2014, 2024 & 2030
- ITALY
- TABLE 95: Italy Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 96: Italy Historic Review for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 97: Italy 16-Year Perspective for Veterinary Molecular Diagnostics by Product Segment - Percentage Breakdown of Value Sales for Instruments & Software, Kits & Reagents and Services for the Years 2014, 2024 & 2030
- TABLE 98: Italy Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 99: Italy Historic Review for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 100: Italy 16-Year Perspective for Veterinary Molecular Diagnostics by Technology Type - Percentage Breakdown of Value Sales for Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing for the Years 2014, 2024 & 2030
- TABLE 101: Italy Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 102: Italy Historic Review for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 103: Italy 16-Year Perspective for Veterinary Molecular Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals/Clinics and Reference Laboratories for the Years 2014, 2024 & 2030
- UNITED KINGDOM
- Veterinary Molecular Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
- TABLE 104: UK Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 105: UK Historic Review for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 106: UK 16-Year Perspective for Veterinary Molecular Diagnostics by Product Segment - Percentage Breakdown of Value Sales for Instruments & Software, Kits & Reagents and Services for the Years 2014, 2024 & 2030
- TABLE 107: UK Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 108: UK Historic Review for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 109: UK 16-Year Perspective for Veterinary Molecular Diagnostics by Technology Type - Percentage Breakdown of Value Sales for Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing for the Years 2014, 2024 & 2030
- TABLE 110: UK Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 111: UK Historic Review for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 112: UK 16-Year Perspective for Veterinary Molecular Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals/Clinics and Reference Laboratories for the Years 2014, 2024 & 2030
- SPAIN
- TABLE 113: Spain Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 114: Spain Historic Review for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 115: Spain 16-Year Perspective for Veterinary Molecular Diagnostics by Product Segment - Percentage Breakdown of Value Sales for Instruments & Software, Kits & Reagents and Services for the Years 2014, 2024 & 2030
- TABLE 116: Spain Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 117: Spain Historic Review for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 118: Spain 16-Year Perspective for Veterinary Molecular Diagnostics by Technology Type - Percentage Breakdown of Value Sales for Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing for the Years 2014, 2024 & 2030
- TABLE 119: Spain Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 120: Spain Historic Review for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 121: Spain 16-Year Perspective for Veterinary Molecular Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals/Clinics and Reference Laboratories for the Years 2014, 2024 & 2030
- RUSSIA
- TABLE 122: Russia Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 123: Russia Historic Review for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 124: Russia 16-Year Perspective for Veterinary Molecular Diagnostics by Product Segment - Percentage Breakdown of Value Sales for Instruments & Software, Kits & Reagents and Services for the Years 2014, 2024 & 2030
- TABLE 125: Russia Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 126: Russia Historic Review for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 127: Russia 16-Year Perspective for Veterinary Molecular Diagnostics by Technology Type - Percentage Breakdown of Value Sales for Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing for the Years 2014, 2024 & 2030
- TABLE 128: Russia Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 129: Russia Historic Review for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 130: Russia 16-Year Perspective for Veterinary Molecular Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals/Clinics and Reference Laboratories for the Years 2014, 2024 & 2030
- REST OF EUROPE
- TABLE 131: Rest of Europe Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 132: Rest of Europe Historic Review for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 133: Rest of Europe 16-Year Perspective for Veterinary Molecular Diagnostics by Product Segment - Percentage Breakdown of Value Sales for Instruments & Software, Kits & Reagents and Services for the Years 2014, 2024 & 2030
- TABLE 134: Rest of Europe Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 135: Rest of Europe Historic Review for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 136: Rest of Europe 16-Year Perspective for Veterinary Molecular Diagnostics by Technology Type - Percentage Breakdown of Value Sales for Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing for the Years 2014, 2024 & 2030
- TABLE 137: Rest of Europe Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 138: Rest of Europe Historic Review for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 139: Rest of Europe 16-Year Perspective for Veterinary Molecular Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals/Clinics and Reference Laboratories for the Years 2014, 2024 & 2030
- ASIA-PACIFIC
- Veterinary Molecular Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
- TABLE 140: Asia-Pacific Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
- TABLE 141: Asia-Pacific Historic Review for Veterinary Molecular Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 142: Asia-Pacific 16-Year Perspective for Veterinary Molecular Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
- TABLE 143: Asia-Pacific Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 144: Asia-Pacific Historic Review for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 145: Asia-Pacific 16-Year Perspective for Veterinary Molecular Diagnostics by Product Segment - Percentage Breakdown of Value Sales for Instruments & Software, Kits & Reagents and Services for the Years 2014, 2024 & 2030
- TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 147: Asia-Pacific Historic Review for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 148: Asia-Pacific 16-Year Perspective for Veterinary Molecular Diagnostics by Technology Type - Percentage Breakdown of Value Sales for Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing for the Years 2014, 2024 & 2030
- TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 150: Asia-Pacific Historic Review for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 151: Asia-Pacific 16-Year Perspective for Veterinary Molecular Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals/Clinics and Reference Laboratories for the Years 2014, 2024 & 2030
- AUSTRALIA
- Veterinary Molecular Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
- TABLE 152: Australia Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 153: Australia Historic Review for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 154: Australia 16-Year Perspective for Veterinary Molecular Diagnostics by Product Segment - Percentage Breakdown of Value Sales for Instruments & Software, Kits & Reagents and Services for the Years 2014, 2024 & 2030
- TABLE 155: Australia Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 156: Australia Historic Review for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 157: Australia 16-Year Perspective for Veterinary Molecular Diagnostics by Technology Type - Percentage Breakdown of Value Sales for Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing for the Years 2014, 2024 & 2030
- TABLE 158: Australia Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 159: Australia Historic Review for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 160: Australia 16-Year Perspective for Veterinary Molecular Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals/Clinics and Reference Laboratories for the Years 2014, 2024 & 2030
- INDIA
- Veterinary Molecular Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
- TABLE 161: India Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 162: India Historic Review for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 163: India 16-Year Perspective for Veterinary Molecular Diagnostics by Product Segment - Percentage Breakdown of Value Sales for Instruments & Software, Kits & Reagents and Services for the Years 2014, 2024 & 2030
- TABLE 164: India Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 165: India Historic Review for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 166: India 16-Year Perspective for Veterinary Molecular Diagnostics by Technology Type - Percentage Breakdown of Value Sales for Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing for the Years 2014, 2024 & 2030
- TABLE 167: India Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 168: India Historic Review for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 169: India 16-Year Perspective for Veterinary Molecular Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals/Clinics and Reference Laboratories for the Years 2014, 2024 & 2030
- SOUTH KOREA
- TABLE 170: South Korea Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 171: South Korea Historic Review for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 172: South Korea 16-Year Perspective for Veterinary Molecular Diagnostics by Product Segment - Percentage Breakdown of Value Sales for Instruments & Software, Kits & Reagents and Services for the Years 2014, 2024 & 2030
- TABLE 173: South Korea Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 174: South Korea Historic Review for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 175: South Korea 16-Year Perspective for Veterinary Molecular Diagnostics by Technology Type - Percentage Breakdown of Value Sales for Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing for the Years 2014, 2024 & 2030
- TABLE 176: South Korea Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 177: South Korea Historic Review for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 178: South Korea 16-Year Perspective for Veterinary Molecular Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals/Clinics and Reference Laboratories for the Years 2014, 2024 & 2030
- REST OF ASIA-PACIFIC
- TABLE 179: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 180: Rest of Asia-Pacific Historic Review for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 181: Rest of Asia-Pacific 16-Year Perspective for Veterinary Molecular Diagnostics by Product Segment - Percentage Breakdown of Value Sales for Instruments & Software, Kits & Reagents and Services for the Years 2014, 2024 & 2030
- TABLE 182: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 183: Rest of Asia-Pacific Historic Review for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 184: Rest of Asia-Pacific 16-Year Perspective for Veterinary Molecular Diagnostics by Technology Type - Percentage Breakdown of Value Sales for Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing for the Years 2014, 2024 & 2030
- TABLE 185: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 186: Rest of Asia-Pacific Historic Review for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 187: Rest of Asia-Pacific 16-Year Perspective for Veterinary Molecular Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals/Clinics and Reference Laboratories for the Years 2014, 2024 & 2030
- LATIN AMERICA
- Veterinary Molecular Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
- TABLE 188: Latin America Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
- TABLE 189: Latin America Historic Review for Veterinary Molecular Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 190: Latin America 16-Year Perspective for Veterinary Molecular Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
- TABLE 191: Latin America Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 192: Latin America Historic Review for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 193: Latin America 16-Year Perspective for Veterinary Molecular Diagnostics by Product Segment - Percentage Breakdown of Value Sales for Instruments & Software, Kits & Reagents and Services for the Years 2014, 2024 & 2030
- TABLE 194: Latin America Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 195: Latin America Historic Review for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 196: Latin America 16-Year Perspective for Veterinary Molecular Diagnostics by Technology Type - Percentage Breakdown of Value Sales for Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing for the Years 2014, 2024 & 2030
- TABLE 197: Latin America Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 198: Latin America Historic Review for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 199: Latin America 16-Year Perspective for Veterinary Molecular Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals/Clinics and Reference Laboratories for the Years 2014, 2024 & 2030
- ARGENTINA
- TABLE 200: Argentina Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 201: Argentina Historic Review for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 202: Argentina 16-Year Perspective for Veterinary Molecular Diagnostics by Product Segment - Percentage Breakdown of Value Sales for Instruments & Software, Kits & Reagents and Services for the Years 2014, 2024 & 2030
- TABLE 203: Argentina Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 204: Argentina Historic Review for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 205: Argentina 16-Year Perspective for Veterinary Molecular Diagnostics by Technology Type - Percentage Breakdown of Value Sales for Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing for the Years 2014, 2024 & 2030
- TABLE 206: Argentina Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 207: Argentina Historic Review for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 208: Argentina 16-Year Perspective for Veterinary Molecular Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals/Clinics and Reference Laboratories for the Years 2014, 2024 & 2030
- BRAZIL
- TABLE 209: Brazil Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 210: Brazil Historic Review for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 211: Brazil 16-Year Perspective for Veterinary Molecular Diagnostics by Product Segment - Percentage Breakdown of Value Sales for Instruments & Software, Kits & Reagents and Services for the Years 2014, 2024 & 2030
- TABLE 212: Brazil Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 213: Brazil Historic Review for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 214: Brazil 16-Year Perspective for Veterinary Molecular Diagnostics by Technology Type - Percentage Breakdown of Value Sales for Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing for the Years 2014, 2024 & 2030
- TABLE 215: Brazil Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 216: Brazil Historic Review for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 217: Brazil 16-Year Perspective for Veterinary Molecular Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals/Clinics and Reference Laboratories for the Years 2014, 2024 & 2030
- MEXICO
- TABLE 218: Mexico Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 219: Mexico Historic Review for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 220: Mexico 16-Year Perspective for Veterinary Molecular Diagnostics by Product Segment - Percentage Breakdown of Value Sales for Instruments & Software, Kits & Reagents and Services for the Years 2014, 2024 & 2030
- TABLE 221: Mexico Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 222: Mexico Historic Review for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 223: Mexico 16-Year Perspective for Veterinary Molecular Diagnostics by Technology Type - Percentage Breakdown of Value Sales for Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing for the Years 2014, 2024 & 2030
- TABLE 224: Mexico Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 225: Mexico Historic Review for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 226: Mexico 16-Year Perspective for Veterinary Molecular Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals/Clinics and Reference Laboratories for the Years 2014, 2024 & 2030
- REST OF LATIN AMERICA
- TABLE 227: Rest of Latin America Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 228: Rest of Latin America Historic Review for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 229: Rest of Latin America 16-Year Perspective for Veterinary Molecular Diagnostics by Product Segment - Percentage Breakdown of Value Sales for Instruments & Software, Kits & Reagents and Services for the Years 2014, 2024 & 2030
- TABLE 230: Rest of Latin America Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 231: Rest of Latin America Historic Review for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 232: Rest of Latin America 16-Year Perspective for Veterinary Molecular Diagnostics by Technology Type - Percentage Breakdown of Value Sales for Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing for the Years 2014, 2024 & 2030
- TABLE 233: Rest of Latin America Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 234: Rest of Latin America Historic Review for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 235: Rest of Latin America 16-Year Perspective for Veterinary Molecular Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals/Clinics and Reference Laboratories for the Years 2014, 2024 & 2030
- MIDDLE EAST
- Veterinary Molecular Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
- TABLE 236: Middle East Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
- TABLE 237: Middle East Historic Review for Veterinary Molecular Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 238: Middle East 16-Year Perspective for Veterinary Molecular Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
- TABLE 239: Middle East Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 240: Middle East Historic Review for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 241: Middle East 16-Year Perspective for Veterinary Molecular Diagnostics by Product Segment - Percentage Breakdown of Value Sales for Instruments & Software, Kits & Reagents and Services for the Years 2014, 2024 & 2030
- TABLE 242: Middle East Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 243: Middle East Historic Review for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 244: Middle East 16-Year Perspective for Veterinary Molecular Diagnostics by Technology Type - Percentage Breakdown of Value Sales for Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing for the Years 2014, 2024 & 2030
- TABLE 245: Middle East Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 246: Middle East Historic Review for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 247: Middle East 16-Year Perspective for Veterinary Molecular Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals/Clinics and Reference Laboratories for the Years 2014, 2024 & 2030
- IRAN
- TABLE 248: Iran Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 249: Iran Historic Review for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 250: Iran 16-Year Perspective for Veterinary Molecular Diagnostics by Product Segment - Percentage Breakdown of Value Sales for Instruments & Software, Kits & Reagents and Services for the Years 2014, 2024 & 2030
- TABLE 251: Iran Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 252: Iran Historic Review for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 253: Iran 16-Year Perspective for Veterinary Molecular Diagnostics by Technology Type - Percentage Breakdown of Value Sales for Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing for the Years 2014, 2024 & 2030
- TABLE 254: Iran Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 255: Iran Historic Review for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 256: Iran 16-Year Perspective for Veterinary Molecular Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals/Clinics and Reference Laboratories for the Years 2014, 2024 & 2030
- ISRAEL
- TABLE 257: Israel Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 258: Israel Historic Review for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 259: Israel 16-Year Perspective for Veterinary Molecular Diagnostics by Product Segment - Percentage Breakdown of Value Sales for Instruments & Software, Kits & Reagents and Services for the Years 2014, 2024 & 2030
- TABLE 260: Israel Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 261: Israel Historic Review for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 262: Israel 16-Year Perspective for Veterinary Molecular Diagnostics by Technology Type - Percentage Breakdown of Value Sales for Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing for the Years 2014, 2024 & 2030
- TABLE 263: Israel Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 264: Israel Historic Review for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 265: Israel 16-Year Perspective for Veterinary Molecular Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals/Clinics and Reference Laboratories for the Years 2014, 2024 & 2030
- SAUDI ARABIA
- TABLE 266: Saudi Arabia Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 267: Saudi Arabia Historic Review for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 268: Saudi Arabia 16-Year Perspective for Veterinary Molecular Diagnostics by Product Segment - Percentage Breakdown of Value Sales for Instruments & Software, Kits & Reagents and Services for the Years 2014, 2024 & 2030
- TABLE 269: Saudi Arabia Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 270: Saudi Arabia Historic Review for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 271: Saudi Arabia 16-Year Perspective for Veterinary Molecular Diagnostics by Technology Type - Percentage Breakdown of Value Sales for Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing for the Years 2014, 2024 & 2030
- TABLE 272: Saudi Arabia Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 273: Saudi Arabia Historic Review for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 274: Saudi Arabia 16-Year Perspective for Veterinary Molecular Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals/Clinics and Reference Laboratories for the Years 2014, 2024 & 2030
- UNITED ARAB EMIRATES
- TABLE 275: UAE Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 276: UAE Historic Review for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 277: UAE 16-Year Perspective for Veterinary Molecular Diagnostics by Product Segment - Percentage Breakdown of Value Sales for Instruments & Software, Kits & Reagents and Services for the Years 2014, 2024 & 2030
- TABLE 278: UAE Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 279: UAE Historic Review for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 280: UAE 16-Year Perspective for Veterinary Molecular Diagnostics by Technology Type - Percentage Breakdown of Value Sales for Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing for the Years 2014, 2024 & 2030
- TABLE 281: UAE Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 282: UAE Historic Review for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 283: UAE 16-Year Perspective for Veterinary Molecular Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals/Clinics and Reference Laboratories for the Years 2014, 2024 & 2030
- REST OF MIDDLE EAST
- TABLE 284: Rest of Middle East Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 285: Rest of Middle East Historic Review for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 286: Rest of Middle East 16-Year Perspective for Veterinary Molecular Diagnostics by Product Segment - Percentage Breakdown of Value Sales for Instruments & Software, Kits & Reagents and Services for the Years 2014, 2024 & 2030
- TABLE 287: Rest of Middle East Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 288: Rest of Middle East Historic Review for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 289: Rest of Middle East 16-Year Perspective for Veterinary Molecular Diagnostics by Technology Type - Percentage Breakdown of Value Sales for Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing for the Years 2014, 2024 & 2030
- TABLE 290: Rest of Middle East Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 291: Rest of Middle East Historic Review for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 292: Rest of Middle East 16-Year Perspective for Veterinary Molecular Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals/Clinics and Reference Laboratories for the Years 2014, 2024 & 2030
- AFRICA
- Veterinary Molecular Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
- TABLE 293: Africa Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 294: Africa Historic Review for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 295: Africa 16-Year Perspective for Veterinary Molecular Diagnostics by Product Segment - Percentage Breakdown of Value Sales for Instruments & Software, Kits & Reagents and Services for the Years 2014, 2024 & 2030
- TABLE 296: Africa Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 297: Africa Historic Review for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 298: Africa 16-Year Perspective for Veterinary Molecular Diagnostics by Technology Type - Percentage Breakdown of Value Sales for Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing for the Years 2014, 2024 & 2030
- TABLE 299: Africa Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 300: Africa Historic Review for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 301: Africa 16-Year Perspective for Veterinary Molecular Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals/Clinics and Reference Laboratories for the Years 2014, 2024 & 2030
IV. COMPETITION